Asher Bio

Asher Bio is a biotechnology firm dedicated to pioneering the next generation of targeted immunotherapies for cancer and various other diseases. Their innovative cis-targeting platform facilitates the selective activation of specific immune cell types, overcoming the limitations of conventional immunotherapies that often affect multiple cell types indiscriminately. This precision-based approach allows for the targeted delivery of diverse immune mediators to specific immune cell populations, paving the way for the development of superior immunotherapies for cancer, autoimmune disorders, and infectious diseases. Supported by Third Rock Ventures, Asher Bio is headquartered in South San Francisco, driving advancements in immunotherapy research and development.